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Accepted 23 June 2010AbstractObjective: The aim of this study was to evaluate fasting serum leptin concentration and its relation to insulin resistance in women with
gestational diabetes mellitus (GDM) and gestational impaired glucose tolerance (IGT).
Materials and Methods: This case-control study, at 28 weeks of gestation, measured serum concentration of fasting leptin, insulin, and
homeostatic model assessment index in three groups, GDM, IGT, and normal control, and compared them with each other.
Results: The serum leptin level was significantly higher in women with GDM than in the two other groups ( p¼ 0.03). In women with GDM and
IGT, leptin was significantly positively related with insulin and homeostatic model assessment index (r¼ 0.221, p¼ 0.03) and (r¼ 0.246,
p¼ 0.03), respectively. In all of the participants, there was a significant correlation between leptin and body mass index before pregnancy
(r¼ 0.416, p¼ 0.001).
Conclusion: Our data showed that serum leptin level was higher in GDM and had a positive correlation with insulin resistance. Our findings
suggest that high leptin levels might be a risk factor for GDM and IGT in pregnant women.
Copyright  2011, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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Disorders of glucose metabolism in pregnancy, such as
gestational diabetes mellitus (GDM) and gestational impaired
glucose tolerance (IGT), complicate pregnancy and these
disorders are the main causes of adverse pregnancy outcomes
[1]. Like all forms of hyperglycemia, GDM is characterized by
insulin levels that are insufficient to meet insulin demands [2].
The pathogenesis of GDM has not been clearly explained.
The most common theory is that GDM is caused by decreasing
insulin sensitivity and increasing anti-insulin hormones
that are secreted by the placenta during pregnancy, such as* Corresponding author. Department of Endocrinology, Yazd Diabetes
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doi:10.1016/j.tjog.2011.01.034human placental lactogen, prolactin, glucocorticoid, and
progesterone [3].
New potential mediators of insulin resistance, including
antiobesity hormone and leptin, have been recently investi-
gated [4]. Leptin is an adipocyte-derived hormone, which is
produced by some tissues, including the stomach, intestine,
and the placenta in humans [4,5], and acts on the receptors of
the hypothalamus to decrease food intake and increase energy
consumption [5]. Some studies suggest that leptin also has
a main effect on the regulation of whole body glucose
homeostasis [6,7]. Some studies demonstrated a positive
correlation between direct and indirect measures of adiposity
with plasma leptin concentrations [8]. In pregnant women with
changes in maternal fat stores and glucose metabolism, leptin
increases [9]. Maternal leptin concentration increases 2e3
times above the nonpregnant concentration with the peak
around 28 weeks of gestation [9]. Some clinical studies implycs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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upregulation of adipocyte leptin synthesis in the presence of
increasing insulin resistance and hyperinsulinemia in the
second half of pregnancy [10]. Researchers have illustrated
that leptin directly affects whole body insulin sensitivity
through regulating the efficiency of insulin-mediated glucose
metabolism by skeletal muscle [11] and by hepatic regulation
of gluconeogenesis [12]. The findings of some studies indicate
that leptin has an acute inhibitory effect on secretion of insulin
[6]. Large epidemiological studies have shown that plasma
leptin concentrations were positively associated with insulin
resistance in men and nonpregnant women [13].
In summary, available data suggest a complex relation
between leptin and glucose homeostasis in humans. To our
best knowledge, only two teams of investigators have studied
maternal leptin concentrations in GDM women and the related
published results are conflicting. On the other hand, the
available data do not clarify whether the alterations in leptin
concentrations are the cause or consequence of the metabolic
disturbances, such as hyperglycemia, that are intrinsic to
GDM. Additionally, the severity of any possible association of
GDM risk with different concentrations of leptin was not
assessed in either study [14,15]. We meant to explore the
relationship of leptin concentration with insulin resistance in
GDM.
Materials and methods
A case-control study was done at the Yazd Diabetes
Research Center in 2007e2008 in Iran. In our study settings,
all pregnant women were screened at 24e28 weeks of gesta-
tion using a 50 g glucose challenge test using Carpenter and
Coustan criteria [16]. Those patients who have abnormal
response accordingly (postload glucose concentrations of
130 mg/dL or higher) underwent a standard 100 g, 3-hour oral
glucose tolerance test (OGTT). Women were diagnosed with
GDM if at least two of four diagnostic criteria were met or
exceeded [fasting plasma glucose (FPG) 95 mg/dL, for 1
hour, 2 hours, and 3 hours was 180 mg/dL, 155 mg/dL,
140 mg/dL, respectively]. Women with one abnormal OGTT
value on the 3-hour OGTT were considered as having gesta-
tional IGT.
By consecutive patient selection, 29 women with GDM, 26
women with IGT, and 27 healthy pregnant women with normal
OGTT were included in our study. Women with pre-GDM,
chronic disease, and hypertension were excluded.
Normal pregnant women were matched with the GDM and
IGT groups according to age, gestational age, and body mass
index (BMI) before pregnancy.
The institution’s Research Ethics Committee approval was
obtained before study enrollment. All subjects gave written
informed consent for participation in the study.
From their medical records, information was obtained,
including maternal age, parity, gestational age, height, pre-
pregnancy weight, reproductive and medical histories, and
prepregnancy BMI (kilogram/meter square). These were
entered in analysis of the data as covariates. Maternal heightand weight were measured by standard methods and BMI was
calculated by dividing the weight in kilograms by the height in
meters squared.
A blood test was done at 28 weeks of gestation. Maternal
fasting plasma samples, collected in 10 mL vacutainer tubes,
were frozen at 80C.
Samples were thawed at room temperature, and then
plasma glucose concentrations were measured in certified
clinical laboratories using photometric method. The intra-
assay coefficient of variation for glucose was 1.7% and
interassay coefficient of variation was 1.1%. This assay had
a sensitivity margin of 5 mg/dL.
Serum leptin concentrations were measured using a sensi-
tive ELISA kit (Biosource Kap 2281, Denmark). The intra-
assay coefficient of variation for the leptin was 4.4%. This
assay had a sensitivity margin of 0.1 ng/mL.
Insulin concentrations were detected from serum using
a human ELISA Kit (Biosource Kap 2281, Denmark). The
intra-assay coefficient of variation for the insulin was 6.3%
and the interassay coefficient of variation was 2%. This assay
had a sensitivity margin of 1 mIu/mL.
The insulin sensitivity index from the OGTTwas calculated
according to the homeostatic model assessment (HOMA)
equation. HOMA is derived from the product of the FPG and
the fasting plasma insulin (FPI) divided by a constant (22.5)
[HOMA¼ (FPG FPI)/22.5] [17].
HOMA index values below 3.0 were considered as normal,
whereas values equal to or above 3.0 indicated severe insulin
resistance. All chemical analyses were done in the medical
laboratory center of Yazd University.
All statistical analyses were performed by using SPSS for
Windows, version 11.5 (SPSS, Inc., Chicago, IL, USA). Data
of continuous variables were expressed as mean standard
deviation and many of our results did not have the normal
distribution so the results were presented as median,
minimum, and maximum values. For comparison of means of
serum leptin between three groups, one-way analysis of vari-
ance was used; and for comparison of means of serum
continuous variables between pairs of groups, the Bonferroni
test was used. The insulin and HOMA index, which were not
normally distributed, were compared using the Kruskal-Wallis
test among the three groups.
For assessment of correlation between variables in the three
groups Pearson correlation was used. Statistical significance
was set at p value less than 0.05.
Results
Eighty-two pregnant women participated in this study,
which included 29 women with GDM, 26 women with the
IGT, and 27 healthy pregnant women with normal OGTT. The
baseline characteristics of the pregnant women are shown in
Table 1.
The serum leptin was significantly higher in women with
GDM compared with the IGT and healthy pregnant women
(p¼ 0.03) (Fig. 1). The difference of serum leptin between
GDM versus the IGT group (p¼ 0.1) and the IGT versus
Table 1
The baseline characteristics of pregnant women who were screened for
gestational diabetes mellitus
Baseline
characteristics
GDM (n¼ 30)
(mean SD)
IGT (n¼ 28)
(mean SD)
Normal (n¼ 31)
(mean SD)
pa
Age (yr) 27.9 6.1 26 .9 5.3 27.3 4.9 0.22
Parity (n) 2.2 1.31 1.5 1.15 2.2 0.97 0.07
BMI (kg/m2) 26.7 3.7 25.7 2.6 26.7 4.5 0.31
Gestational
age (wk)
25.6 1.4 25.4 0.9 26.1 1.1 0.23
a By one-way ANOVA.
ANOVA¼ analysis of variance; GDM¼ gestational diabetes mellitus;
IGT¼ impaired glucose tolerance; SD¼ standard deviation.
Table 2
Mean (SD) or median (interquartile range) of leptin, fasting blood sugar,
insulin concentrations, and HOMA index in pregnant women with GDM, IGT,
and normal glucose homeostasis
Parameters GDM (n¼ 30) IGT (n¼ 28) Normal (n¼ 31) p
Leptin (ng/mL)a,b 30.60 (33.40) 24.10 (17.07) 21.60 (12.60) 0.03
Insulin (IU/mL)c 26.84 5.3 20.7 3.6 11.8 4.9 0.04
HOMA indexc 6.68 1.3 5.1 1.07 2.3 0.9 0.04
Fasting blood sugar
(mg/dL)c,d
98.7 14.78 97 7.29 83 23.6 0.07
a Women with GDM versus normal group ( p< 0.05).
b Median/interquartile range.
c Mean SD.
d Women with IGT versus normal group ( p< 0.05).
GDM¼ gestational diabetes mellitus; HOMA¼ homeostatic model assess-
ment; IGT¼ impaired glucose tolerance; SD¼ standard deviation.
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women with GDM, FPG, insulin, and HOMA index were
higher than in the normal group (Table 2).
In all of the participants, there was a significant correlation
between leptin and BMI before pregnancy (r¼ 0.416,
p¼ 0.001) and insulin levels (r¼ 0.221, p¼ 0.04). There was
a positive correlation between leptin, insulin, and HOMA
index in GDM (r¼ 0.221, p¼ 0.03), (r¼ 0.246, p¼ 0.03).
Leptin had a negative correlation with age and parity
(r¼0.04, p¼ 0.72), (r¼0.103, p¼ 0.38), and a positive
correlation with gestational age (r¼ 0.219, p¼ 0.06), but
these correlations were not significant. We used the odds ratio
to establish the cutoff point for leptin level and a receiver
operating characteristic curve was drawn. Leptin level
20.5 ng/mL could be a predictor for the risk of GDM
(sensitivity 80%, specificity 50%) (Fig. 2).
Discussion
Women with GDM had higher serum leptin concentrations
than IGT and non-GDM women. Our results are generally
consistent with studies that assessed maternal plasma leptinGroup 
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Fig. 1. Comparison between the mean of leptin (ng/mL) in pregnant women
with GDM, IGT, and normal glucose homeostasis. CI¼ confidence interval;
GDM¼ gestational diabetes mellitus; IGT¼ impaired glucose tolerance.concentrations in pregnancies complicated by GDM. In a case-
control study, Kautzky-Willer et al [15] reported that maternal
third-trimester plasma leptin concentrations were higher in
GDM women compared with the control group (24.9 ng/mL
vs. 18.2 ng/mL; p¼ 0.001). Such a relation was also found in
the Vitoratus et al [18] and Qiu et al [19] studies. Liu et al [20]
showed that serum leptin level is correlated with glucose
tolerance during pregnancy.
However, Festa et al [14], in an earlier case-control study,
noted that maternal third-trimester leptin concentrations were
significantly lower in GDM cases as compared with controls
after adjusting for possible confounding factors, such as BMI
and insulin concentrations. Several possible explanations are
suggested for the disparities in the existing studies. The studyFig. 2. ROC curve of threshold leptin levels for predicting GDM. Serum leptin
level 20.5 ng/mL could be the predictor threshold point for GDM (sensitivity
80%, specificity 50%). GDM¼ gestational diabetes mellitus; ROC¼ receiver
operating characteristic.
152 S. Soheilykhah et al. / Taiwanese Journal of Obstetrics & Gynecology 50 (2011) 149e153design and the confounding factors, such as the time of blood
sampling (whether blood samples were collected before, after,
or during labor) and maternal factors, including whether
women were treated with medication or diet before blood was
collected for leptin determination, might account for differ-
ences. Moreover, variations in population characteristics and
status of glycemic control could also account for some of the
observed differences in study results. An important limitation
of the two available studies is the design of those studies in
which leptin concentrations were determined after the diag-
nosis of GDM. In this case, it cannot be determined whether
any observed alterations in plasma leptin concentrations
preceded GDM or whether the differences might be attributed
to disease-related alterations in glucose metabolism [19].
In a nested case-control study by Gao et al [3], 22 women
with GDM, 10 with IGT, and 20 healthy pregnant women were
chosen from the women who had visited at 14e20 weeks of
gestation and had blood samples prospectively taken and kept
during their visit. Findings of this study showed that women
with GDM have the highest values of leptin compared with
those with IGT and the healthy controls at 14e20 weeks of
gestation.
Some studies evaluated the relationship between leptin
concentration and insulin resistance. Maghbooli et al [21]
found that leptin concentration was positively associated
with insulin level and HOMA index. Liu et al [20] showed
a positive and significant correlation between the maternal
leptin and fasting insulin levels. Our results indicate that
plasma insulin levels are higher in GDM and IGT compared
with the normal group, and the serum leptin had a significant
positive correlation with insulin and HOMA index.
However, Mohiti et al [22] reported that the serum leptin
had a negative correlation with insulin in obese diabetic
patients.
Our findings are consistent with a much larger body of
evidence from experimental, clinical, and epidemiological
investigations, which suggest that leptin is an important
mediator of glucose homeostasis in humans and plasma leptin
has a significant positive correlation with BMI. Liu et al [20]
also has shown that leptin predicts the development of GDM
independent of maternal BMI and other risk factors. The
findings of this prospective study are generally consistent with
the reports by Kautzky-Willer et al [15], Lappas et al [23] and
Qiu et al [19], as well.
Our finding showed that the predicting threshold for GDM
was serum leptin levels20.5 ng/mL, but as the area under the
curve is less that 80%, this threshold is not the best predicting
point for leptin in GDM women. So, we need a prospective
study in larger population of GDM women.
In conclusion, we found that patients with GDM had higher
serum leptin levels than IGT and non-GDM women, and
women with higher BMI had a higher level of leptin
concentration. These results show the presence of an associ-
ation between serum leptin level and glucose metabolism in
GDM. As to whether the high leptin levels can serve as
a predictive factor for GDM development, larger prospective
studies are needed to address this issue.Acknowledgments
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